Muscular Dystrophy Dystroglycanopathy Congenital With Brain And Eye Anomalies Type A 7 C3553330
A severe congenital muscular dystrophy causing muscle weakness, brain malformations, and eye abnormalities. Symptoms present at birth or early infancy. Management is supportive; condition is often life-limiting.
Key facts at a glance
- ICD-10
- Q79.9
- ICD-11
- LA00.0
- Body system
- musculoskeletal
- Severity
- fatal
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Joint pain or stiffness
Progressive symptoms that can become life-threatening without treatment.
Seek immediate medical attention if symptoms worsen.
Ocular abnormalities
Seizures
Congenital muscle weakness
(musculoskeletal)Developmental delay
(neurological)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Early Intervention Motor Therapy
Aggressive physical therapy program beginning in infancy to maximize motor development within individual capabilities. Focuses on gross motor skills, positioning, and preventing secondary complications.
Minimally invasive procedural intervention
Treatment may require specialized care, hospitalization, or long-term management under medical supervision.
Ophthalmologic Surveillance
Regular comprehensive eye examinations monitoring for retinal changes, cataracts, and visual impairment. Early identification allows for educational interventions and vision aids.
Additional treatment options
Seizure Management Surgery
When seizures are refractory to medical management, surgical evaluation including potential resection or vagus nerve stimulation may be considered. Requires comprehensive presurgical mapping.
surgicalModified Texture Diet
As swallowing difficulties develop, texture-modified diets ensure adequate nutrition while minimizing aspiration risk. Collaboration with speech therapy guides appropriate food consistency.
dietaryDevelopmental Support Services
Comprehensive psychological and educational support addressing cognitive delays and behavioral challenges. Includes cognitive stimulation, skill-building, and family training.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is Muscular Dystrophy Dystroglycanopathy Congenital With Brain And Eye Anomalies Type A 7 C3553330?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Bönnemann CG, Muntoni F, Sewry CA. Congenital muscular dystrophies with brain and eye malformations: molecular genetics and clinical phenotypes. Neuromuscul Disord. 2020.
Kang PB, Byrne PL, Connolly AM, et al. International Consensus Guidance on Management of Dystroglycanopathies. Neurology. 2022.
Mercuri E, Messina S, Bruno C, et al. Clinical spectrum and genetic basis of dystroglycanopathy type A: a prospective cohort study. Brain. 2019.
Ohtake A, Hayashi YK, Nishikawa A, et al. Diagnostic yield of genetic testing in congenital muscular dystrophy with brain and eye involvement: systematic review and meta-analysis. Orphanet J Rare Dis. 2021.
Medication Comparisons
Compare medications used to treat Muscular Dystrophy Dystroglycanopathy Congenital With Brain And Eye Anomalies Type A 7 C3553330. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy